These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38809980)

  • 21. Endocannabinoid liberation from neurons in transsynaptic signaling.
    Lovinger DM
    J Mol Neurosci; 2007 Sep; 33(1):87-93. PubMed ID: 17901551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presynaptic mGluRs Control the Duration of Endocannabinoid-Mediated DSI.
    Colmers PLW; Bains JS
    J Neurosci; 2018 Dec; 38(49):10444-10453. PubMed ID: 30355625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CB1 receptors down-regulate a cAMP/Epac2/PLC pathway to silence the nerve terminals of cerebellar granule cells.
    Alonso B; Bartolomé-Martín D; Ferrero JJ; Ramírez-Franco J; Torres M; Sánchez-Prieto J
    J Neurochem; 2017 Aug; 142(3):350-364. PubMed ID: 28445587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production.
    Galante M; Diana MA
    J Neurosci; 2004 May; 24(20):4865-74. PubMed ID: 15152047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum.
    Musella A; Fresegna D; Rizzo FR; Gentile A; Bullitta S; De Vito F; Guadalupi L; Centonze D; Mandolesi G
    Sci Rep; 2017 Aug; 7(1):7363. PubMed ID: 28779174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
    Mátyás F; Urbán GM; Watanabe M; Mackie K; Zimmer A; Freund TF; Katona I
    Neuropharmacology; 2008 Jan; 54(1):95-107. PubMed ID: 17655884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolution and comparative neurobiology of endocannabinoid signalling.
    Elphick MR
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3201-15. PubMed ID: 23108540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
    Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
    J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling.
    Hons IM; Storr MA; Mackie K; Lutz B; Pittman QJ; Mawe GM; Sharkey KA
    Neurogastroenterol Motil; 2012 Mar; 24(3):e113-24. PubMed ID: 22235973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
    Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
    Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
    Hoffman AF; Laaris N; Kawamura M; Masino SA; Lupica CR
    J Neurosci; 2010 Jan; 30(2):545-55. PubMed ID: 20071517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses.
    Younts TJ; Chevaleyre V; Castillo PE
    J Neurosci; 2013 Aug; 33(34):13743-57. PubMed ID: 23966696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromodulation via conditional release of endocannabinoids in the spinal locomotor network.
    Kettunen P; Kyriakatos A; Hallén K; El Manira A
    Neuron; 2005 Jan; 45(1):95-104. PubMed ID: 15629705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local interneurons regulate synaptic strength by retrograde release of endocannabinoids.
    Beierlein M; Regehr WG
    J Neurosci; 2006 Sep; 26(39):9935-43. PubMed ID: 17005857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex.
    Lemtiri-Chlieh F; Levine ES
    J Neurophysiol; 2010 Oct; 104(4):1923-32. PubMed ID: 20719932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.
    Roloff AM; Thayer SA
    Mol Pharmacol; 2009 Apr; 75(4):892-900. PubMed ID: 19118122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presynaptic modulation by endocannabinoids.
    Lovinger DM
    Handb Exp Pharmacol; 2008; (184):435-77. PubMed ID: 18064422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
    Nyilas R; Gregg LC; Mackie K; Watanabe M; Zimmer A; Hohmann AG; Katona I
    Eur J Neurosci; 2009 May; 29(10):1964-78. PubMed ID: 19453631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals.
    Nyilas R; Dudok B; Urbán GM; Mackie K; Watanabe M; Cravatt BF; Freund TF; Katona I
    J Neurosci; 2008 Jan; 28(5):1058-63. PubMed ID: 18234884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.